Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin-Reference-Cited by-同舟云学术

Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin

Published:2017-08-29 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Garg Manoj,Kanojia Deepika,Mayakonda Anand,Ganesan Trivadi S,Sadhanandhan Bindhya,Suresh Sidhanth,S. Sneha,Nagare Rohit P.,Said Jonathan W.,Doan Ngan B.,Ding Ling-Wen^ORCID,Baloglu Erkan,Shacham Sharon,Kauffman Michael,Koeffler H. Phillip^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-10325-x.pdf

Reference50 articles.

1. Robbins, J. et al. Thyroid cancer: a lethal endocrine neoplasm. Annals of internal medicine 115, 133–147 (1991).

2. Ain, K. B. Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches. Thyroid: official journal of the American Thyroid Association 8, 715–726 (1998).

3. Sherman, S. I. Thyroid carcinoma. Lancet 361, 501–511 (2003).

4. O’Neill, J. P. & Shaha, A. R. Anaplastic thyroid cancer. Oral oncology 49, 702–706, doi: 10.1016/j.oraloncology.2013.03.440 (2013).

5. Perri, F., Lorenzo, G. D., Scarpati, G. D. & Buonerba, C. Anaplastic thyroid carcinoma: A comprehensive review of current and future therapeutic options. World journal of clinical oncology 2, 150–157, doi: 10.5306/wjco.v2.i3.150 (2011).

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tackling the Moving Mutant Target: Taxifolin Derivatives as Novel Putative E571K Exportin-1 Inhibitors for KRAS-mutant Lung Adenocarcinoma;2024 International Conference on Science, Engineering and Business for Driving Sustainable Development Goals (SEB4SDG);2024-04-02

2. CircRNA ITCH Inhibits Epithelial–Mesenchymal Transformation and Promotes Apoptosis in Papillary Thyroid Carcinoma via miR-106a-5p/JAZF1 Axis;Biochemical Genetics;2024-02-15

3. The development and validation of a liquid chromatography tandem mass spectrometry method for the quantification of selinexor and its application in Chinese multiple myeloma patients;Analytical Methods;2024

4. Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects;European Journal of Medical Research;2023-09-14

5. Phytochemical Profiles and Anticancer Effects of Calophyllum inophyllum L. Extract Relating to Reactive Oxygen Species Modulation on Patient-Derived Cells from Breast and Lung Cancers;Scientifica;2023-07-20